OIA
ALXN

OneDigital Investment Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

OneDigital Investment Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-102
Closed -$13K – 1255
2019
Q2 		$13K Buy
102
+14
+16% +$1.8K ﹤0.01% 902
2019
Q1 		$12K Buy
88
+13
+17% +$1.62K ﹤0.01% 851
2018
Q4 		$7K Sell
75
-11
-13% -$1.3K ﹤0.01% 925
2018
Q3 		$12K Hold
86
– – ﹤0.01% 798
2018
Q2 		$11K Buy
86
+16
+23% +$1.87K ﹤0.01% 1024
2018
Q1 		$8K Buy
70
+12
+21% +$1.43K ﹤0.01% 1086
2017
Q4 		$7K Hold
58
– – ﹤0.01% 1050
2017
Q3 		$8K Buy
58
+7
+14% +$951 ﹤0.01% 843
2017
Q2 		$6K Buy
+51
New +$5.94K ﹤0.01% 1039

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OneDigital Investment Advisors's ALXN Position: Q3 2019 in Review

OneDigital Investment Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2019, closing a stake of 102 shares — an estimated $13K sold.

OneDigital Investment Advisors first reported a position in ALXN in Q2 2017 and held it in 9 quarters. The position peaked at $13K in Q2 2019. 647 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

  • OneDigital Investment Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • OneDigital Investment Advisors sold 102 Alexion Pharmaceuticals shares in Q3 2019, an estimated $13K.
  • OneDigital Investment Advisors first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 9 quarters.
  • OneDigital Investment Advisors's Alexion Pharmaceuticals position peaked at $13K in Q2 2019.
  • 647 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on OneDigital Investment Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.